Expression of EIF1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

EIF1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 341.24

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

335.6

Number of samples

141

Samples

Sample	Description	TPM
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	544.7
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	544.0
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	541.8
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	506.1
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	473.0
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	468.3
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	465.0
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	463.8
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	461.6
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	434.7
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	432.0
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	430.5
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	420.8
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	417.8
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	412.8
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	411.3
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	409.2
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	407.2
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	406.8
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	405.6
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	402.8
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	401.7
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	400.7
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	398.5
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	398.2
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	398.0
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	396.5
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	395.3
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	394.7
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	394.1
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	393.5
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	392.6
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	390.8
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	389.1
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	383.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	382.9
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	381.9
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	381.3
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	380.0
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	379.3
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	378.3
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	378.1
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	375.5
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	374.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	374.0
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	372.5
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	371.1
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	370.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	368.6
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	367.4
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	366.6
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	364.7
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	361.4
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	361.4
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	358.4
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	352.3
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	351.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	351.2
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	348.7
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	348.3
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	347.0
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	344.6
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	344.2
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	342.0
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	341.9
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	340.5
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	338.8
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	338.1
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	335.6
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	335.2
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	333.4
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	332.8
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	332.2
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	331.7
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	331.0
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	329.5
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	329.3
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	327.1
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	325.1
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	324.5
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	323.3
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	318.8
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	318.0
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	317.5
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	316.0
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	314.8
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	313.4
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	313.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	311.7
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	310.8
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	309.1
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	308.9
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	308.0
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	306.9
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	302.7
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	301.8
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	300.5
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	300.4
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	299.2
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	298.2
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	297.9
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	297.4
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	296.0
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	292.2
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	291.5
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	289.5
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	286.9
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	284.5
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	284.4
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	280.9
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	280.9
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	278.6
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	276.2
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	274.0
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	272.6
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	267.0
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	265.3
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	264.7
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	264.4
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	261.8
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	260.0
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	259.3
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	256.5
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	256.0
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	252.8
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	245.8
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	245.3
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	243.7
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	239.7
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	238.3
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	234.0
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	230.1
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	228.7
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	220.7
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	220.0
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	204.8
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	202.6
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	179.8
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	174.8
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	171.6
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	69.4
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

EIF1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 69.89

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

56.3

Number of samples

Samples

Sample	Description	TPM
AK205	N, NA, stage:NA, dead, 120 days	127.0
AK117	N, NA, stage:NA, dead, 210 days	99.4
AK099	N, NA, stage:NA, dead, 420 days	95.1
AK195	N, NA, stage:NA, dead, 390 days	88.4
AK002	N, NA, stage:NA, dead, 570 days	88.3
AK055	N, NA, stage:NA, dead, 240 days	86.4
AK227	N, NA, stage:NA, alive, 300 days	83.3
AK178	N, NA, stage:NA, dead, 240 days	76.7
AK226	N, NA, stage:NA, dead, 360 days	72.8
AK149	N, NA, stage:NA, dead, 420 days	72.2
AK218	N, NA, stage:NA, dead, 180 days	72.1
AK123	N, NA, stage:NA, dead, 180 days	71.8
AK133	N, NA, stage:NA, dead, 360 days	70.8
AK030	N, NA, stage:NA, dead, 120 days	70.7
AK134	N, NA, stage:NA, dead, 360 days	69.9
AK043	N, NA, stage:NA, alive, 660 days	69.8
AK085	N, NA, stage:NA, alive, 660 days	66.3
AK089	N, NA, stage:NA, dead, 330 days	64.9
AK081	N, NA, stage:NA, dead, 180 days	64.2
AK088	N, NA, stage:NA, dead, 360 days	64.1
AK068	N, NA, stage:NA, alive, 360 days	61.0
AK076	N, NA, stage:NA, alive, 660 days	59.5
AK005	N, NA, stage:NA, dead, 240 days	58.5
AK072	N, NA, stage:NA, dead, 150 days	58.4
AK035	N, NA, stage:NA, dead, 210 days	57.9
AK079	N, NA, stage:NA, dead, 210 days	57.3
AK156	N, NA, stage:NA, dead, 330 days	57.2
AK041	N, NA, stage:NA, alive, 810 days	54.7
AK091	N, NA, stage:NA, dead, 210 days	53.9
AK006	N, NA, stage:NA, dead, 360 days	53.7
AK103	N, NA, stage:NA, alive, 1320 days	51.2
AK003	N, NA, stage:NA, dead, 600 days	50.7
AK236	N, NA, stage:NA, dead, 360 days	50.1
AK188	N, NA, stage:NA, alive, 420 days	49.2
AK173	N, NA, stage:NA, dead, 180 days	48.7
AK167	N, NA, stage:NA, dead, 180 days	48.2
AK158	N, NA, stage:NA, dead, 360 days	47.7
AK100	N, NA, stage:NA, alive, 960 days	47.6
AK071	N, NA, stage:NA, dead, 540 days	46.4
AK142	N, NA, stage:NA, alive, 90 days	45.1
AK216	N, NA, stage:NA, dead, 360 days	43.3
AK183	N, NA, stage:NA, alive, 360 days	41.6
AK102	N, NA, stage:NA, alive, 1740 days	41.0
AK051	N, NA, stage:NA, dead, 360 days	40.3
AK049	N, NA, stage:NA, dead, 180 days	39.5
AK185	N, NA, stage:NA, alive, 330 days	38.8
AK153	N, NA, stage:NA, dead, 240 days	38.1
AK124	N, NA, stage:NA, alive, 1920 days	37.7
AK231	N, NA, stage:NA, dead, 240 days	36.3
AK053	N, NA, stage:NA, dead, 300 days	36.2
AK015	N, NA, stage:NA, alive, 720 days	36.0
AK199	N, NA, stage:NA, alive, 1860 days	34.9
AK066	N, NA, stage:NA, alive, 960 days	33.6
AK165	N, NA, stage:NA, alive, 360 days	30.0
AK139	N, NA, stage:NA, dead, 270 days	29.4
AK213	N, NA, stage:NA, alive, 2010 days	28.7
AK074	N, NA, stage:NA, alive, 300 days	26.6
AK098	N, NA, stage:NA, dead, 660 days	23.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0205780003	Tumor	0.8
CPT0161730003	Tumor	0.8
CPT0206560003	Tumor	0.6
CPT0087950003	Tumor	0.6
CPT0168380003	Tumor	0.6
CPT0071100003	Tumor	0.5
CPT0218330004	Tumor	0.5
CPT0093360003	Tumor	0.4
CPT0219080004	Tumor	0.4
CPT0217000004	Tumor	0.4
CPT0104220003	Tumor	0.4
CPT0207030003	Tumor	0.3
CPT0186100003	Tumor	0.3
CPT0196850003	Tumor	0.3
CPT0127480003	Tumor	0.3
CPT0206110003	Tumor	0.3
CPT0125220003	Tumor	0.3
CPT0168480003	Tumor	0.3
CPT0204350003	Normal	0.3
CPT0125570003	Tumor	0.3
CPT0167530003	Tumor	0.3
CPT0167970003	Tumor	0.2
CPT0162020003	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0168080003	Tumor	0.2
CPT0206780003	Tumor	0.2
CPT0209440003	Tumor	0.2
CPT0217100003	Tumor	0.2
CPT0190360004	Tumor	0.2
CPT0217430008	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0217710008	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0221180003	Tumor	0.2
CPT0204400003	Normal	0.2
CPT0218690004	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0228220003	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0171580008	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0218670003	Tumor	0.1
CPT0204420003	Normal	0.1
CPT0167860004	Tumor	0.1
CPT0123530003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0078580003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0206330003	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0093450003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0224390004	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0093510003	Tumor	0.1
CPT0204380003	Normal	0.1
CPT0205890003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0087680003	Tumor	0.1
CPT0064890003	Tumor	0.1
CPT0204330003	Normal	0.1
CPT0206880003	Tumor	0.1
CPT0204360003	Normal	0.0
CPT0125510003	Tumor	0.0
CPT0189750004	Tumor	0.0
CPT0204370003	Normal	0.0
CPT0206230003	Tumor	0.0
CPT0217190003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0218770003	Tumor	0.0
CPT0224540004	Tumor	0.0
CPT0168720003	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0208980003	Tumor	-0.1
CPT0162140003	Tumor	-0.1
CPT0217880003	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0204340003	Normal	-0.1
CPT0224600003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0190240004	Tumor	-0.1
CPT0189250003	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0205450004	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0204390003	Normal	-0.2
CPT0092440003	Tumor	-0.2
CPT0079790003	Tumor	-0.2
CPT0093550003	Tumor	-0.2
CPT0218960004	Tumor	-0.2
CPT0168590003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0216920008	Tumor	-0.3
CPT0207090003	Tumor	-0.3
CPT0002410011	Tumor	-0.3
CPT0224330003	Tumor	-0.3
CPT0168270003	Tumor	-0.3
CPT0204410003	Normal	-0.3
CPT0218830004	Tumor	-0.4
CPT0189650004	Tumor	-0.6
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis